“multiple-sclerosis” Archives

in
Entry Author Date Location
Federation Bio Bags $50M to Engineer New Approach to Microbiome Drugs 10/06/20 Boston
Sanofi Reaches $3.68B Deal to Buy Principia and Partnered MS Drug 08/17/20 Europe
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info 05/13/20 New York
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch 03/26/20 New York
Quench Bio Springs From Atlas With $50M for a New Take on Inflammation 01/27/20 Boston
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Acorda Cuts Staff 25% and Restructures to Keep Focus on Parkinson’s Drug 10/24/19 New York
Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO 10/01/19 New York
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds 09/06/19 Boston
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
For GW Pharma CEO Justin Gover, The CBD Trend Started 20 Years Ago 08/26/19 San Diego
Skyhawk Inks Deal With Genentech for Cancer and Neuro Drug Discovery 07/16/19 Boston
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Amid Acquisition Drama, Celgene Resubmits MS Drug for FDA Approval 03/25/19 New York
Adieu to Adu: Biogen’s Big Alzheimer’s Bet Flops, Shares Routed 03/21/19 Boston
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Celgene Submits MS Drug for Approval in Europe, FDA Filing on Track 03/11/19 New York
Alexion Hits Study Goals, Could Expand Blockbuster Drug to CNS 09/24/18 Boston
Entasis Therapeutics and Principia Biopharma Join the IPO Queue 08/20/18 Boston
Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M 07/23/18 San Francisco
Pliant Picks Up $62M to Test Lung, Liver Fibrosis Drug in the Clinic 07/16/18 San Francisco
Westphal’s Flex Pharma To Cut Jobs and Seek Sale After Clinical Flop 06/13/18 Boston
Akili Grabs $55M, Seeking FDA Approval of First Video Game Therapy 05/09/18 Boston
Roche Buys Inception 5 MS Program, Versant Funds New Venture 04/04/18 San Diego
Despite Pharma Ties, Some Patient Groups Protest High Drug Prices 03/12/18 National
FDA Refuses to Review Celgene’s MS Drug, Says File “Insufficient” 02/27/18 New York
Page 1 of 9 next page »